Navigation Links
Lilly CEO Lechleiter Outlines Opportunities for Improved Health and Economic Growth in Asia-Pacific Region
Date:11/10/2011

ndustries, such as the biopharmaceutical industry."  

He noted that industries that center on intellectual property employ more than 19 million Americans and account for some 60 percent of total U.S. exports.

Innovation and Collaboration to Address NCDs

Addressing the impact of non-communicable disease (NCDs) in the developing world will require a two-pronged approach that emphasizes both innovation and strategic partnerships.  

"Non-communicable diseases – including cardiovascular disease, cancer, chronic respiratory disease, and diabetes – are by far the leading cause of death in the Asia-Pacific region and the world," Lechleiter said. He cited a number of compelling figures:

  • Of the 57 million deaths globally in 2008, 36 million, or 63 percent, were due to NCDs.
  • Some 80 percent of all NCD deaths occur in low- and middle-income countries.
  • While the increase in NCDs reflects in part the aging of world populations, one in four who died from NCDs in 2008 (9 million people) was under the age of 60.

Lechleiter noted that the cost of NCDs is economic as well as human. "As this scourge of premature death and disability takes lives, it also destroys opportunities and has profound economic consequences – adding to poverty, halting development, and weakening communities."  

He commended the APEC economies on their recent endorsement of the APEC Action Plan to Reduce the Economic Burden of NCDs, which guides APEC economies as they implement new programs and initiatives to prevent and mitigate NCDs.

"There will be no single solution to the challenge of NCDs – the work of finding and implementing effective approaches will be as complex as the diseases themselves," Lechleiter said. "By making the investments to find and deliver the next wave of innovative medicines, research-based companies can play a critical role
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
2. Lilly CEO Says Appropriate Assessment of Both Benefits and Risks Critical in Regulatory Process
3. Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership
4. Lilly Provides Update on 2011 Financial Guidance Due to Xigris Withdrawal
5. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
6. Lilly Reports Third-Quarter 2011 Results
7. Lilly Declares Fourth-Quarter 2011 Dividend
8. Lilly Announces Changes in Senior Management
9. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
10. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
11. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology company ... announced today that Daniel P. Gold , Ph.D., President ... America Merrill Lynch 2015 Health Care Conference on Wednesday, May ... at the Wynn in Las Vegas . ... www.meipharma.com . A replay will be available approximately one ...
(Date:5/6/2015)... 6, 2015 - Annual List ... Technology Solution Providers 2015 - Indegene Makes ... Life Sciences Technology Solution Providers for its Clinical, Commercial, ... Organizations CIO Review (cioreview.com) has chosen Indegene ... Sciences Technology Solution Providers 2015. The positioning is based ...
(Date:5/6/2015)... , May 6, 2015 Adaptive Biotechnologies, ... (NGS) of T-cell and B-cell receptors in the ... Series F financing round with a $195 million ... round was led by Matrix Capital Management and ... Management, Rock Springs Capital and an additional large ...
Breaking Medicine Technology:MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2CIO Review Selects Indegene for 20 Most Promising Pharma and Life Sciences Technology Solution Providers 2015 2Adaptive Biotechnologies Enhances Leading Position in Growing Immunosequencing Market with Completion of $195 Million Investment 2
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Nabumetone Tablets USP, 500 mg and 750 mg. The ... equivalent to Nabumetone Tablets, a treatment for osteoarthritis and ...
... and TULSA, Okla. , July 14 ... prescribing strategic alliance to increase the availability of important ... Tamoxitest™. These tests and the GeneMedRx medication management software ... to personalize their prescribing practices in order to prevent ...
Cached Medicine Technology:Mylan Receives Approval for Nabumetone Tablets 2Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor for Genelex Corporation 2
(Date:5/6/2015)... A poker run to raise funds for the 2015 National Veterans ... will start at the United Veterans Club, 1914 W. Capital Ave, ... run, participants will visit checkpoints, drawing a card at each one. ... end of the run. The run will start at the United ... Fairmont American Legion, Hastings DAV post, Kearney American Legion and finish ...
(Date:5/6/2015)... May 06, 2015 With an estimated ... subject to its potentially dangerous health effects, the Horizon ... – BEAM (Breathe Easier with Asthma Management) – to ... is being funded through a $500,000 foundation grant to ... which is implementing BEAM throughout the state. , “While ...
(Date:5/6/2015)... Lexington, Mass. (PRWEB) May 06, 2015 ... company, today announced that CTO David Ting will lead ... including the associated data security and user authentication challenges, ... Orlando, Fla.). The session will focus on the benefits ... devices in which care providers and patients can share ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair company, ... now conduct their cooling services, including air conditioning repair ... and residential units. Strata complex air conditioning services are ... knowledge as well as a professionally trained staff. ... away any old air conditioning unit to be recycled, ...
(Date:5/6/2015)... Baptist Medical Center Jacksonville and the ... Florida and southeast Georgia region offering MAKOplasty® Hip ... total hip replacement surgery performed using the RIO® ... enables the accurate alignment and positioning of implants. ... partial knee resurfacing using the RIO system since ...
Breaking Medicine News(10 mins):Health News:Updated Contacts: Poker Run Fundraiser to Benefit National Veterans Golden Age Games 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4
... , , BANNOCKBURN, Ill., ... men in the United States(1). Yet it,s often not until the untimely ... Mays or Tim Russert - that the issue is brought to the ... a heightened focus on heart health, a recent survey(2) uncovered that only ...
... 65 could reach 1.3 billion by 2040 , MONDAY, July ... age 65 and older will double from 7 to 14 ... new U.S. Census Bureau study. , The over-65 population worldwide ... 1.3 billion in 30 years. The unprecedented rate of increase ...
... , , WHITE PLAINS, N.Y. and ... Society (LLS) and FORMA Therapeutics today announced a partnership to accelerate ... , The collaboration will begin with ... academic researchers, deemed to have the most promise of advancing into ...
... , , , ... provider of Health Management Solutions, today announced the appointment of Michael Unhjem ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090709/FL43703LOGO ... and chief executive officer of Blue Cross Blue Shield (BCBS) of North ...
... WALTHAM, Mass., July 20 Decision Resources, one of the ... issues, finds that most surveyed clinicians identify a need for ... classes for the treatment of type 2 diabetes. In particular, ... owing to the shortcomings of the current GLP-1 analogue, Amylin/Eli ...
... , , ZURICH, July 20 N y comed tod a y announced t h e ... Food a n d Drug Administr a tion ... on c e-dail y oral treatme n t for patie ... . Th e NDA subm i ssion is ba s e d on enc ou raging result s ...
Cached Medicine News:Health News:Need for At-Home Blood Pressure Monitoring Underscored by High-Profile Cardiac Deaths 2Health News:Need for At-Home Blood Pressure Monitoring Underscored by High-Profile Cardiac Deaths 3Health News:Elder Boom Will Be Felt Worldwide 2Health News:The Leukemia & Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 2Health News:The Leukemia & Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 3Health News:Michael Unhjem Appointed to Board of Directors for Health Integrated 2Health News:Michael Unhjem Appointed to Board of Directors for Health Integrated 3Health News:For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors 2Health News:For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors 3Health News:Nycomed Announces FDA Filing for Daxas(R) in COPD 2Health News:Nycomed Announces FDA Filing for Daxas(R) in COPD 3
... Plus is a CO2 laser system ... W. Its functions in continuous and ... requiring extreme laser intervention delicacy. Excellent ... studios, it comes with a large ...
... a professional digital imaging system for ophthalmology ... need to acquire, analyze, and store your ... you use the most are,available right on ... and easily. This high-resolution system supports images ...
Pain management can be complicated. But that doesn't mean your PCA infusion system should be. The new SYNDEO PCA Syringe Pump streamlines pain therapy with a powerful combination of intelligent desig...
... 20 years, AMS has provided laboratory ... industrial clients in a partnership that ... and Economy. Always striving with dedication ... the individual needs of each client ...
Medicine Products: